Bispecific Antibody Treatment in Non-Hodgkin Lymphoma: Glofitamab - Blood Cancers OncTalk 2023 GRACE - Global Resource for Advancing Cancer Education 2:52 6 months ago 63 Скачать Далее
The benefits of glofitamab in R/R DLBCL post-CAR-T therapy VJHemOnc – Video Journal of Hematology & HemOnc 1:15 1 year ago 726 Скачать Далее
Glofitamab, a CD20/CD3 bispecific antibody, in the treatment of R/R DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 7:48 1 month ago 165 Скачать Далее
Phase II study of glofitamab in patients with R/R LBCL VJHemOnc – Video Journal of Hematology & HemOnc 2:40 2 years ago 444 Скачать Далее
Insights into Phase I/II study assessing fixed-duration glofitamab treatment for R/R LBCL VJHemOnc – Video Journal of Hematology & HemOnc 2:43 1 year ago 195 Скачать Далее
Impact of TMTV on PFS following glofitamab treatment in R/R DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 2:21 5 months ago 97 Скачать Далее
Relapsed and Refractory Diffuse Large B-Cell Lymphoma Lymphoma Research Foundation 46:48 1 year ago 5 073 Скачать Далее
Updated results of glofitamab plus polatuzumab vedotin combination therapy in DLBCL, including HGBCL VJHemOnc – Video Journal of Hematology & HemOnc 2:54 6 months ago 220 Скачать Далее
Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cell Lymphoma GRACE - Global Resource for Advancing Cancer Education 3:02 2 months ago 118 Скачать Далее
Glofitamab induces durable complete remissions in patients with relapsed large B-cell lymphoma ecancer 4:46 2 years ago 679 Скачать Далее
Glofitamab: a valuable agent for the treatment of patients with R/R mantle cell lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 2:00 1 year ago 131 Скачать Далее
Glofitamab as a single agent in heavily pretreated patients with DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 2:33 1 year ago 275 Скачать Далее
Glofitamab in R/R DLBCL: updated safety and efficacy data VJHemOnc – Video Journal of Hematology & HemOnc 5:30 9 months ago 384 Скачать Далее
Advantages of bispecific antibodies for lymphoma: mosunetuzumab, epcoritamab & glofitamab VJHemOnc – Video Journal of Hematology & HemOnc 1:31 1 year ago 666 Скачать Далее
Treatment Options of B-Cell Lymphoma: Glofitamab vs. Epcoritamab - Blood Cancer Video Library 2023 GRACE - Global Resource for Advancing Cancer Education 4:22 19 hours ago No Скачать Далее
Mitigating CRS following glofitamab treatment in R/R DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 2:33 5 months ago 139 Скачать Далее
ASH highlights: glofitamab in DLBCL & pirtobrutinib and epcoritamab in Richter's transformation VJHemOnc – Video Journal of Hematology & HemOnc 1:58 1 year ago 336 Скачать Далее
The STARGLO trial: glofitamab in combination with gemcitabine and oxaliplatin in R/R DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 2:04 1 month ago 168 Скачать Далее
Extended follow-up of glofitamab monotherapy in R/R LBCL: durability of CR and likelihood of CRS VJHemOnc – Video Journal of Hematology & HemOnc 3:58 6 months ago 175 Скачать Далее
Michael Dickinson, MBBS, DMedSc, on a Phase II Trial of Glofitamab in DLBCL Blood Cancers Today 6:47 1 year ago 179 Скачать Далее
